Investigation of a novel biomarker, neuropilin-1, and its application for poor prognosis in acute myeloid leukemia patients

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6919-6924

  Zhao, Jianqiang ^a   Gu, Liufang ^b   Li, Chengliang ^a   Ma, Weiguo ^a   Ni, Zengfeng ^a  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Biomarker; Neuropilin 1; Overall survival; Prognosis

Indexed keywords

BIOLOGICAL MARKER; COMPLEMENTARY DNA; NEUROPILIN 1; RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CHILD; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROPILIN-1; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84904988875     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1942-9     Document Type: Article

References (24)

1. Jiang L, Yu G, Meng W, Wang Z, Meng F, Ma W. Overexpression of amyloid precursor protein in acute myeloid leukemia enhances extramedullary infiltration by MMP-2. Tumor Biol. 2013;34(2): 629-36.
2. Tian Y, Huang Z, Wang Z, Yin C, Zhou L, Zhang L, et al. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1, Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia. PLoS ONE. 2014;9(1):e84150.
3. National cancer institute. SEER stat fact sheets: acute myeloid leukemia available from: http://seer.cancer.Gov/statfacts/html/amyl.html. Accessed June 16, 2013.
4. Memarian A, Nourizadeh M, Masoumi F, Tabrizi M, Emami AH, Alimoghaddam K, et al. Upregulation of CD200 is associated with Foxp2 regulatory T cell expansion and disease progression in acute myeloid leukemia. Tumor Biol. 2013;34(1):531-42.
5. Damm F, Heuser M, Morgan M, Wagner K, Gorlich K, Grosshennig A, et al. Integrative prognostic risk score in acute myeloid leukemia with normal karyotype. Blood. 2011;117(17):4561-8.
6. Vales A, Kondo R, Aichberger KJ, Mayerhofer M, Kainz B, Sperr WR, et al. Myeloid leukemias expression a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. Leuk Lymphoma. 2007;48(10):1997-2007. (Pubitemid 47542987)
7. Latil A, Bieche I, Pesche S, Valeri A, Fournier G, Cussenot O. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int J Cancer. 2000;89(2):167-71. (Pubitemid 30185926)
8. Lu L, Zhang L, Xiao Z, Lu S, Yang R, Han ZC. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk Lymphoma. 2008;49(2):331-8. (Pubitemid 351193927)
9. Staber PB, Linkesch W, Zauner D, Beham-Schmid C, Guelly C, Schauer S, et al. Common alterations in the gene expression and increased proliferation in recurrent acute myeloid leukemia. Oncogene. 2004;23(4):894-904. (Pubitemid 38250934)
10. Kreuter M. Downregulation of neuropilin-1 in patients with acute myeloid leukemia treated with thalidomide. Eur J Haematol. 2007;79(5):392-7. (Pubitemid 47556495)
11. Sallam TH, EI Telbany MA, Mahmoud HM,Iskander MA. Significance of neuropilin-1 expression in acute myeloid leukemia. Turk J Haematol. 2013;30(3):300-6.
12. Zacchigna S, Pattarini L, Zentilin L, Moimas S, Carrer A, Sinigaglia M, et al. Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. J Clin Invest. 2008;118(6):2062-75. (Pubitemid 351872326)
13. Xu K, Wang X, Shi Q, Chen C, Tian C, Li XL, et al. Human prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosis. J Mol Neurosci. 2011;43(3):225-34.
14. Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21(24):4642-9. (Pubitemid 46594039)
15. Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood. 2005;106(4):1154-63. (Pubitemid 41130866)
16. Juliusson G, Antunovic P, Derolf A, Lehmann S, Mollgard L, Stockelberg D, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113(18):4179-87.
17. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-74.
18. Campos-Mora M, Morales RA, Gajardo T, Catalan D, Pino-Lagos K. Neuropilin-1 in transplantation tolerance. Front Immunol. 2013;4(1):405.
19. Takagi S, Tsuji T, Amagai T, Takamatsu T, Fujisawa H. Specific cell surface labels in the visual centers of Xenopus laevis tadpole identified using monoclonal antibodies. Dev Biol. 1987;122(1):90-100. (Pubitemid 17113172)
20. Staton CA, Kumar I, Reed MW, Brown N. Neuropilins in physiological and pathological angiogenesis. J Pathol. 2007;212(3):237-48. (Pubitemid 47010058)
21. Matsushita A, Gotze T, Korc M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res. 2007;67(21):10309-16. (Pubitemid 350070805)
22. Dabrowska M, Skoneczny M, Rode W. Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumor Biol. 2011;32(5):965-76.
23. Pellet-Many C, Frankel P, Evans IM, Herzog B, Junemann-Ramirez M, Zachary IC. Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signaling via p130Cas. Biochem J. 2011;435(3):609-18.
24. Vilardi BM, Bravo-Calderon DM, Bemabe DG, Oliveira SH, Oliveira DT. VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors. Tumor Biol. 2013;34(1):139-43.